| 0 |
Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] |
75 |
0.0230 |
| 1 |
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
203 |
0.0091 |
| 2 |
Human Immunoglobulin G [EPC] |
77 |
0.0037 |
| 3 |
Cytomegalovirus pUL97 Kinase Inhibitor [EPC] |
8 |
0.0032 |
| 4 |
Bispecific CD20-directed CD3 T Cell Engager [EPC] |
9 |
0.0022 |
| 5 |
Nucleoside Analog Antiviral [EPC] |
171 |
0.0020 |
| 6 |
Diagnostic Dye [EPC] |
1 |
0.0015 |
| 7 |
CD19-directed Chimeric Antigen Receptor [EPC] |
12 |
0.0012 |
| 8 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
130 |
0.0010 |
| 9 |
Alkylating Drug [EPC] |
195 |
0.0008 |
| 10 |
Dihydrofolate Reductase Inhibitor Antimalarial [EPC] |
1 |
0.0008 |
| 11 |
Monobactam Antibacterial [EPC] |
2 |
0.0007 |
| 12 |
Antimetabolite Immunosuppressant [EPC] |
10 |
0.0005 |
| 13 |
CD20-directed Cytolytic Antibody [EPC] |
148 |
0.0005 |
| 14 |
Topoisomerase Inhibitor [EPC] |
35 |
0.0005 |
| 15 |
Osmotic Diuretic [EPC] |
2 |
0.0004 |
| 16 |
Protease Inhibitor [EPC] |
16 |
0.0004 |
| 17 |
CD52-directed Cytolytic Antibody [EPC] |
6 |
0.0003 |
| 18 |
Cytochrome P450 3A Inhibitor [EPC] |
16 |
0.0003 |
| 19 |
Cannabinoid [EPC] |
2 |
0.0002 |
| 20 |
Neonatal Fc Receptor Blocker [EPC] |
1 |
0.0002 |
| 21 |
Selective T Cell Costimulation Blocker [EPC] |
1 |
0.0002 |
| 22 |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
24 |
0.0002 |
| 23 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
10 |
0.0002 |
| 24 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
24 |
0.0002 |
| 25 |
Antimalarial [EPC] |
2 |
0.0002 |
| 26 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
21 |
0.0002 |
| 27 |
Antiprotozoal [EPC] |
2 |
0.0002 |
| 28 |
Corticosteroid [EPC] |
220 |
0.0002 |
| 29 |
CD38-directed Cytolytic Antibody [EPC] |
1 |
0.0002 |
| 30 |
Azole Antifungal [EPC] |
25 |
0.0002 |
| 31 |
Lipid-based Polyene Antifungal [EPC] |
2 |
0.0002 |
| 32 |
Sphingosine 1-phosphate Receptor Modulator [EPC] |
2 |
0.0001 |
| 33 |
Purine Antimetabolite [EPC] |
14 |
0.0001 |
| 34 |
Folate Analog Metabolic Inhibitor [EPC] |
56 |
0.0001 |
| 35 |
Echinocandin Antifungal [EPC] |
1 |
0.0001 |
| 36 |
Nucleoside Metabolic Inhibitor [EPC] |
32 |
0.0001 |
| 37 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
11 |
0.0001 |
| 38 |
Glinide [EPC] |
1 |
0.0001 |
| 39 |
CD30-directed Immunoconjugate [EPC] |
1 |
0.0001 |
| 40 |
Penem Antibacterial [EPC] |
3 |
0.0001 |
| 41 |
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
2 |
0.0001 |
| 42 |
Antimycobacterial [EPC] |
2 |
0.0001 |
| 43 |
Bile Acid Sequestrant [EPC] |
1 |
0.0001 |
| 44 |
Glycopeptide Antibacterial [EPC] |
5 |
0.0001 |
| 45 |
Fluoroquinolone Antibacterial [EPC] |
9 |
0.0001 |
| 46 |
Phenothiazine [EPC] |
2 |
0.0001 |
| 47 |
Platinum-based Drug [EPC] |
18 |
0.0001 |
| 48 |
BCL-2 Inhibitor [EPC] |
4 |
0.0001 |
| 49 |
Leukocyte Growth Factor [EPC] |
9 |
0.0001 |
| 50 |
Interleukin-1 Receptor Antagonist [EPC] |
1 |
0.0001 |
| 51 |
Complement Inhibitor [EPC] |
3 |
0.0001 |
| 52 |
Janus Kinase Inhibitor [EPC] |
8 |
0.0000 |
| 53 |
Polyene Antifungal [EPC] |
2 |
0.0000 |
| 54 |
Xanthine Oxidase Inhibitor [EPC] |
8 |
0.0000 |
| 55 |
Bile Acid [EPC] |
1 |
0.0000 |
| 56 |
Central alpha-2 Adrenergic Agonist [EPC] |
2 |
0.0000 |
| 57 |
Provitamin D2 Compound [EPC] |
1 |
0.0000 |
| 58 |
Nitroimidazole Antimicrobial [EPC] |
2 |
0.0000 |
| 59 |
Kinase Inhibitor [EPC] |
16 |
0.0000 |
| 60 |
Proteasome Inhibitor [EPC] |
3 |
0.0000 |
| 61 |
Histamine-2 Receptor Antagonist [EPC] |
3 |
0.0000 |
| 62 |
Aminosalicylate [EPC] |
2 |
0.0000 |
| 63 |
Proton Pump Inhibitor [EPC] |
11 |
0.0000 |
| 64 |
Peroxisome Proliferator Receptor alpha Agonist [EPC] |
1 |
0.0000 |
| 65 |
Serotonin-3 Receptor Antagonist [EPC] |
2 |
0.0000 |
| 66 |
Opioid Agonist [EPC] |
4 |
0.0000 |
| 67 |
Cardiac Glycoside [EPC] |
1 |
0.0000 |
| 68 |
Aldosterone Antagonist [EPC] |
2 |
0.0000 |
| 69 |
Prostaglandin Analog [EPC] |
1 |
0.0000 |
| 70 |
beta-Adrenergic Blocker [EPC] |
3 |
0.0000 |
| 71 |
Antirheumatic Agent [EPC] |
1 |
0.0000 |
| 72 |
Dihydropyridine Calcium Channel Blocker [EPC] |
3 |
0.0000 |
| 73 |
Anti-epileptic Agent [EPC] |
2 |
0.0000 |
| 74 |
Sulfonylurea [EPC] |
1 |
0.0000 |
| 75 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
10 |
0.0000 |
| 76 |
Selective T Cell Costimulation Modulator [EPC] |
1 |
0.0000 |
| 77 |
Osmotic Laxative [EPC] |
2 |
0.0000 |
| 78 |
Angiotensin 2 Receptor Blocker [EPC] |
2 |
0.0000 |
| 79 |
Benzodiazepine [EPC] |
4 |
0.0000 |
| 80 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
1 |
0.0000 |
| 81 |
Tumor Necrosis Factor Blocker [EPC] |
5 |
0.0000 |
| 82 |
Thiazide Diuretic [EPC] |
1 |
0.0000 |
| 83 |
Loop Diuretic [EPC] |
2 |
0.0000 |
| 84 |
Insulin Analog [EPC] |
1 |
0.0000 |
| 85 |
Atypical Antipsychotic [EPC] |
1 |
0.0000 |
| 86 |
Platelet Aggregation Inhibitor [EPC] |
1 |
0.0000 |